X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-05 | NTLA | Leonard John M | Pres, CEO | S - Sale | $9.21 | -34,146 | 1,071,754 | -3% | -$314,485 | ||||||
2026-01-05 | NTLA | Schultes Birgit C | EVP, Chief Scientific Officer | S - Sale | $9.21 | -8,508 | 98,533 | -8% | -$78,359 | ||||||
2026-01-05 | NTLA | Basta James | EVP, GC | S - Sale | $9.21 | -10,397 | 101,528 | -9% | -$95,756 | ||||||
2026-01-05 | NTLA | Cohen Fred E | Dir | P - Purchase | $9.35 | +150,000 | 207,453 | +261% | +$1,402,500 | ||||||
2026-01-05 | NTLA | Lebwohl David | EVP, Chief Medical Officer | S - Sale | $9.21 | -11,903 | 121,249 | -9% | -$109,627 | ||||||
2026-01-05 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $9.21 | -9,515 | 87,118 | -10% | -$87,633 | ||||||
2026-01-05 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $9.21 | -6,379 | 99,683 | -6% | -$58,751 | ||||||
2026-01-05 | NTLA | Dube Michael P | VP, Chief Accounting Officer | S - Sale | $9.21 | -2,989 | 52,277 | -5% | -$27,529 | ||||||
| D | 2025-12-11 | NTLA | Leonard John M | Pres, CEO | S - Sale+OE | $9.49 | -88,146 | 1,105,900 | -7% | -$836,384 | |||||
2025-10-01 | NTLA | Schultes Birgit C | EVP, Chief Scientific Officer | S - Sale | $17.38 | -31 | 105,184 | 0% | -$539 | ||||||
2025-10-01 | NTLA | Dube Michael P | VP, Chief Accounting Officer | S - Sale | $17.38 | -1,871 | 55,266 | -3% | -$32,518 | ||||||
2025-08-20 | NTLA | Chase William J | Dir | P - Purchase | $10.03 | +100,000 | 134,693 | +288% | +$1,003,000 | ||||||
2025-07-23 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $14.02 | -7,462 | 106,062 | -7% | -$104,617 | ||||||
2025-07-01 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $9.82 | -1,022 | 95,369 | -1% | -$10,036 | ||||||
2025-07-02 | NTLA | Dube Michael P | VP, Chief Accounting Officer | S - Sale | $9.95 | -2,503 | 57,137 | -4% | -$24,905 | ||||||
| M | 2025-06-30 | NTLA | Goodman Jesse | Dir | S - Sale | $9.40 | -3,094 | 24,359 | -11% | -$29,068 | |||||
2025-04-29 | NTLA | Bhanji Muna | Dir | S - Sale | $8.50 | -265 | 19,203 | -1% | -$2,253 | ||||||
| D | 2025-03-04 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale+OE | $8.99 | -679 | 95,369 | -1% | -$6,104 | |||||
| D | 2025-03-04 | NTLA | Basta James | EVP, GC | S - Sale+OE | $8.99 | -2,572 | 111,925 | -2% | -$23,122 | |||||
2025-01-29 | NTLA | Bhanji Muna | Dir | S - Sale | $9.97 | -265 | 19,468 | -1% | -$2,642 | ||||||
2025-01-03 | NTLA | Dube Michael P | VP, Chief Accounting Officer | S - Sale | $12.18 | -1,372 | 45,640 | -3% | -$16,711 | ||||||
2025-01-03 | NTLA | Basta James | EVP, GC | S - Sale | $12.18 | -7,074 | 74,497 | -9% | -$86,161 | ||||||
2025-01-03 | NTLA | Lebwohl David | EVP, Chief Medical Officer | S - Sale | $12.18 | -9,557 | 87,666 | -10% | -$116,404 | ||||||
2025-01-03 | NTLA | Hicks Derek | EVP, Chief Business Officer | S - Sale | $12.18 | -6,502 | 59,878 | -10% | -$79,194 | ||||||
2025-01-03 | NTLA | Leonard John M | Pres, CEO | S - Sale | $12.18 | -26,807 | 999,530 | -3% | -$326,509 | ||||||
2025-01-03 | NTLA | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S - Sale | $12.18 | -8,966 | 77,388 | -10% | -$109,206 | ||||||
| M | 2025-01-02 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $12.17 | -7,978 | 64,048 | -11% | -$97,089 | |||||
2024-10-02 | NTLA | Dube Michael P | VP, Chief Accounting Officer | S - Sale | $19.01 | -2,012 | 47,012 | -4% | -$38,248 | ||||||
2024-07-01 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale | $22.93 | -405 | 71,470 | -1% | -$9,287 | ||||||
2024-06-17 | NTLA | Verwiel Frank | Dir | S - Sale | $25.00 | -1,505 | 17,948 | -8% | -$37,625 | ||||||
| D | 2024-03-04 | NTLA | Basta James | EVP, GC | S - Sale+OE | $32.99 | -2,297 | 81,571 | -3% | -$75,778 | |||||
| D | 2024-03-04 | NTLA | Clark Eliana | EVP, Chief Technical Officer | S - Sale+OE | $32.99 | -605 | 71,470 | -1% | -$19,959 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |